Cart (0 Items)
Your cart is currently empty.
View Products-
-
-
Etrolizumab Biosimilar – Anti-ITGA4_ITGB7 mAb – Research Grade
| Size | 100ug, 1MG |
|---|---|
| Isotype | IgG1, kappa |
| Brand | ProteoGenix |
| Product type | Primary Antibodies |
| Clonality | Monoclonal Antibody |
| Expression system | Mammalian cells |
| Applications | Elisa, WB |
| Product name | Etrolizumab Biosimilar - Anti-ITGA4_ITGB7 mAb - Research Grade |
|---|---|
| Source | CAS 1044758-60-2 |
| Species | Humanized |
| Purity | >85% |
| Buffer | PBS buffer PH7.5 |
| Delivery condition | Blue ice (+4°C) |
| Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed |
| Storage condition | store at -80°C |
| Brand | ProteoGenix |
| Aliases /Synonyms | Etrolizumab,Anti-Beta7,PRO145223,RG7413,rhuMAb Beta7,ITGA4_ITGB7,anti-ITGA4_ITGB7 |
| Reference | PX-TA1255 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
| Isotype | IgG1-kappa |
| Clonality | Monoclonal Antibody |
Description of Etrolizumab Biosimilar - Anti-ITGA4_ITGB7 mAb - Research Grade
General information on Anti-ITGA4_ITGB7[Homo sapiens] (Etrolizumab) Monoclonal Antibody
Etrolizumab has investigated for the treatment of Crohn Disease and Ulcerative Colitis.
Related products
Antigen
ITGA4 recombinant protein
PX-P5178 392$
Isotype Control
Human IgG1 LALA Isotype Control antibody (HyHEL-10)
PTX17885 215$Contact us
Send us a message from the form below
Reviews
There are no reviews yet.